Milwaukee health officials are in communication with three people who recently traveled to the city from central Africa, where a fast-growing Ebola outbreak has infected more than 1,000 people. The ...

Scientists across the country are expressing alarm as the Trump administration dismantles another tool for understanding how the planet is changing. More than 900 deep-sea ocean sensors will be pulled ...

The Trump administration is targeting one of the world’s most trusted sources of climate and oceanic data—the Ocean Observatories Initiative (OOI). According to the New York Times, ships will be ...

Your county tax office isn’t open after hours. Neither is your local DMV. And that’s OK. But a government agency responsible for monitoring people accused of murder and capital murder shouldn’t keep ...

Scientists have pioneered a new way to monitor sodium levels in the blood—without drawing a single drop. By combining terahertz radiation and optoacoustic detection, they created a non-invasive system ...

OpenAI’s latest voice AI model, GPT Realtime 2, introduces advanced capabilities for natural and context-aware interactions. Built on the GPT-5-level reasoning framework, it handles complex tasks such ...

OpenAI said Thursday that its API will now include a number of new voice intelligence features designed to help developers create apps that can talk, transcribe, and translate conversations with users ...

May 7 (Reuters) - OpenAI introduced three audio models for its developer platform on Thursday, aiming to make voice-based software agents more ‌conversational and capable of completing tasks in real ...

WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency ...

All new vehicles sold in the United States will be required to include impaired-driving detection technology by 2027 under a federal safety initiative designed to reduce traffic fatalities caused by ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.

At the 2026 BiOS conference in San Francisco, researchers presented a biosensing platform aimed at improving how living cells and tissues are monitored during drug bioprocessing. Known as TissueSense, ...